(Q71784139)
Statements
Docetaxel in advanced ovarian cancer: preliminary results from three phase II trials. EORTC Early Clinical Trials Group and Clinical Screening Group, and the MD Anderson Cancer Center (English)
S B Kaye
M Piccart
M Aapro